Asthma of difficult control linked to pulmonary thromboembolism and bronchopulmonary aspergillosis

Background: Inflammation caused by chronic diseases and the constant use of systemic corticosteroids could be linked to the increased incidence of venous thromboembolic disease. Clinical case: A 47 year-old man with severe asthma of difficult control and allergic bronchopulmonary aspergillosis who...

Full description

Bibliographic Details
Main Authors: Liliana Guevara-Saldaña, Libia Susana Díez-Zuluaga, Catalina María Gómez-Henao, Ricardo Cardona
Format: Article
Language:English
Published: Colegio Mexicano de Inmunología Clínica y Alergia, A.C. 2019-04-01
Series:Revista Alergia México
Subjects:
Online Access:http://revistaalergia.mx/ojs/index.php/ram/article/view/352
_version_ 1797719787333222400
author Liliana Guevara-Saldaña
Libia Susana Díez-Zuluaga
Catalina María Gómez-Henao
Ricardo Cardona
author_facet Liliana Guevara-Saldaña
Libia Susana Díez-Zuluaga
Catalina María Gómez-Henao
Ricardo Cardona
author_sort Liliana Guevara-Saldaña
collection DOAJ
description Background: Inflammation caused by chronic diseases and the constant use of systemic corticosteroids could be linked to the increased incidence of venous thromboembolic disease. Clinical case: A 47 year-old man with severe asthma of difficult control and allergic bronchopulmonary aspergillosis who, although the treatment was optimal, continued to have recurrent exacerbations and the need for systemic corticosteroids. He had edema in his left leg. Through venous Doppler ultrasound, deep vein thrombosis was confirmed; because of the images of the pulmonary V/Q gammagram, the presence of chronic pulmonary thromboembolism was suspected. 5 mg of apixaban were prescribed every 12 hours; in less than two months, symptom control was achieved without hospitalization, systemic corticosteroids or short-acting B2 agonists. Gradual withdrawal of omalizumab was started with good tolerance. Conclusions: The important decrease of bronchial symptoms with the blood thinner confirmed the suspicion that the exacerbations were caused by chronic pulmonary thromboembolism.
first_indexed 2024-03-12T09:09:53Z
format Article
id doaj.art-665728bb8c504e33848086514a3d4668
institution Directory Open Access Journal
issn 0002-5151
2448-9190
language English
last_indexed 2024-03-12T09:09:53Z
publishDate 2019-04-01
publisher Colegio Mexicano de Inmunología Clínica y Alergia, A.C.
record_format Article
series Revista Alergia México
spelling doaj.art-665728bb8c504e33848086514a3d46682023-09-02T15:02:21ZengColegio Mexicano de Inmunología Clínica y Alergia, A.C.Revista Alergia México0002-51512448-91902019-04-0166112813110.29262/ram.v66i1.352396Asthma of difficult control linked to pulmonary thromboembolism and bronchopulmonary aspergillosisLiliana Guevara-Saldaña0Libia Susana Díez-Zuluaga1Catalina María Gómez-Henao2Ricardo Cardona3Universidad de Antioquia, Grupo de Alergología Clínica y Experimental, AntioquiaUniversidad de Antioquia, Grupo de Alergología Clínica y Experimental, AntioquiaUniversidad de Antioquia, Grupo de Alergología Clínica y Experimental, AntioquiaUniversidad de Antioquia, Grupo de Alergología Clínica y Experimental, AntioquiaBackground: Inflammation caused by chronic diseases and the constant use of systemic corticosteroids could be linked to the increased incidence of venous thromboembolic disease. Clinical case: A 47 year-old man with severe asthma of difficult control and allergic bronchopulmonary aspergillosis who, although the treatment was optimal, continued to have recurrent exacerbations and the need for systemic corticosteroids. He had edema in his left leg. Through venous Doppler ultrasound, deep vein thrombosis was confirmed; because of the images of the pulmonary V/Q gammagram, the presence of chronic pulmonary thromboembolism was suspected. 5 mg of apixaban were prescribed every 12 hours; in less than two months, symptom control was achieved without hospitalization, systemic corticosteroids or short-acting B2 agonists. Gradual withdrawal of omalizumab was started with good tolerance. Conclusions: The important decrease of bronchial symptoms with the blood thinner confirmed the suspicion that the exacerbations were caused by chronic pulmonary thromboembolism.http://revistaalergia.mx/ojs/index.php/ram/article/view/352tromboembolismo pulmonarasmaaspergilosis broncopulmonaresteroides
spellingShingle Liliana Guevara-Saldaña
Libia Susana Díez-Zuluaga
Catalina María Gómez-Henao
Ricardo Cardona
Asthma of difficult control linked to pulmonary thromboembolism and bronchopulmonary aspergillosis
Revista Alergia México
tromboembolismo pulmonar
asma
aspergilosis broncopulmonar
esteroides
title Asthma of difficult control linked to pulmonary thromboembolism and bronchopulmonary aspergillosis
title_full Asthma of difficult control linked to pulmonary thromboembolism and bronchopulmonary aspergillosis
title_fullStr Asthma of difficult control linked to pulmonary thromboembolism and bronchopulmonary aspergillosis
title_full_unstemmed Asthma of difficult control linked to pulmonary thromboembolism and bronchopulmonary aspergillosis
title_short Asthma of difficult control linked to pulmonary thromboembolism and bronchopulmonary aspergillosis
title_sort asthma of difficult control linked to pulmonary thromboembolism and bronchopulmonary aspergillosis
topic tromboembolismo pulmonar
asma
aspergilosis broncopulmonar
esteroides
url http://revistaalergia.mx/ojs/index.php/ram/article/view/352
work_keys_str_mv AT lilianaguevarasaldana asthmaofdifficultcontrollinkedtopulmonarythromboembolismandbronchopulmonaryaspergillosis
AT libiasusanadiezzuluaga asthmaofdifficultcontrollinkedtopulmonarythromboembolismandbronchopulmonaryaspergillosis
AT catalinamariagomezhenao asthmaofdifficultcontrollinkedtopulmonarythromboembolismandbronchopulmonaryaspergillosis
AT ricardocardona asthmaofdifficultcontrollinkedtopulmonarythromboembolismandbronchopulmonaryaspergillosis